Lv11
45 积分 2021-10-18 加入
Radiation as an immune modulator: mechanisms and implications for combination with immunotherapy
2小时前
已完结
Treatment landscape of triple-negative breast cancer — expanded options, evolving needs
1天前
已完结
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer
2天前
已完结
NEJM at ESMO — Overall Survival with Pembrolizumab in Early-Stage Triple- Negative Breast Cancer
2天前
已关闭
Neoadjuvant tislelizumab plus nab-paclitaxel and carboplatin for triple-negative breast cancer: a multicenter, open-label, phase II cTRIO study
2天前
已关闭
Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer
2天前
已完结
Neoadjuvant anthracycline followed by toripalimab combined with nab-paclitaxel in patients with early triple-negative breast cancer (NeoTENNIS): a single-arm, phase II study
2天前
已完结
Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer: The CamRelief Randomized Clinical Trial
2天前
已完结
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer
3天前
已完结
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
3天前
已完结
皖公网安备34019202002308
